[1] SAKLAYEN M G.The global epidemic of the metabolic syndrome.[J].Curr Hypertens Rep,2018,20(2):12.
[2] TANG W H W,BÄCKHED F,LANDMESSER U,et al.Intestinal microbiota in cardiovascular health and disease[J].Circ Res,2019,73(16):2089-2105.
[3] SCR T,PM H.In vivo safety assessment of lactobacillus fermentum strains,evaluation of their cholesterol-lowering ability and intestinal microbial modulation.[J].J Sci Food Agric,2020,100(2):705-713.
[4] MARTÍN-NÚÑEZ G M,CORNEJO-PAREJA I,ROCA-RODRÍGUEZ M,et al.H.Pylori eradication treatment causes alterations in the gut microbiota and blood lipid levels.[J].Front Med(Lausanne),2020,7:417.
[5] SCHOELER M,CAESAR R.Dietary lipids,gut microbiota and lipid metabolism[J] Rev Endocr Metab Disord,2019,20(4):461-472.
[6] LINDSKOG J A,CAESAR R,AKRAMI R,et al.Impact of gut microbiota and diet on the development of atherosclerosis in Apoe-/- mice[J].Arterioscler Thromb Vasc Biol,2018,38(10):2318-2326.
[7] GRANADO-SERRANO A B,MARTÍN-GARÍ M,SÁNCHEZ V,et al.Faecal bacterial and short-chain fatty acids signature in hypercholesterolemia[J].Sci Rep,2019,9(1):1772.
[8] MIYAMOTO J,OHUE-KITANO R,MUKOUYAMA H,et al.Ketone body receptor gpr43 regulates lipid metabolism under ketogenic conditions[J].Proc Natl Acad Sci U S A.2019,116(47):23813-23821.
[9] MCGLONE E R,BLOOM S R.Bile acids and the metabolic syndrome.[J].Ann Clin Biochem,2019,56(3):326-337.
[10] HUANG F,ZHENG X,MA X,et al.Theabrownin from pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism.[J].Nat Commun,2019,10(1):4971.
[11] CHAVEZ-TALAVERA O,TAILLEUX A,LEFEBVRE P,et al.Bile acid control of metabolism and inflammation in obesity,type 2 diabetes,dyslipidemia,and nonalcoholic fatty liver disease[J].Gastroenterology,2017,52(7):1679-1694.
[12] YAN Y,LIU K,LIAN W W,et al.Research progress on roles of gut microbiota in cardiovascular disease and treatment[J].Chin J Clin Pharmacol Ther,2020,25(07):829-834.
[13] O'KEEFE J H,TORRES-ACOSTA N,O'KEEFE E L,et al.A pesco-mediterranean diet with intermittent fasting:jacc review topic of the week.[J].J Am Coll Cardiol,2020,76(12):1484-1493.
[14] MIZOWAKI Y,SUGAWARA S,YAMAMOTO K,et al.Comparison of the effects of the 1975 Japanese diet and the modern mediterranean diet on lipid metabolism in mice[J].J Oleo Sci,2017,66(5):507-519.
[15] KOETH R A,LAM-GALVEZ B R,KIRSOP J,et al.L-carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.[J].J Clin Invest,2019,29(1):373-387.
[16] OLAS B.Probiotics,prebiotics and synbiotics-a promising strategy in prevention and treatment of cardiovascular diseases?[J].Int J Mol Sci,2020,21(24):9737.
[17] NIAMAH A K,SAHI A A,AL-SHARIFI A S N.Effect of feeding soy milk fermented by probiotic bacteria on some blood criteria and weight of experimental animals[J].Probiotics Antimicrob Proteins,2017,9(3):284-291.
[18] MO R,ZHANG X,YANG Y.Effect of probiotics on lipid profiles in hypercholesterolaemic adults:a meta-analysis of randomized controlled trials[J].Med Clin(Barc),2019,152(12):473-481.
[19] AOE S,MIO K,YAMANAKA C,et al.Low molecular weight barley β-glucan affects glucose and lipid metabolism by prebiotic effects[J].Nutrients,2020,13(1):523-536.
[20] DALILE B,VAN OUDENHOVE L,VERVLIET B,et al.The role of short-chain fatty acids in microbiota-gut-brain communication[J].Nat Rev Gastroenterol Hepatol,2019,16(8):461-478.
[21] RASMUSSEN S H,SHRESTHA S,BJERREGAARD L G,et al.Antibiotic exposure in early life and childhood overweight and obesity:a systematic review and Meta-analysis[J].Diabetes Obes Metab,2018,20(6):1508-1514.
[22] MUELLER N T,WHYATT R,HOEPNER L,et al.Prenatal exposure to antibiotics,cesarean section and risk of childhood obesity[J].Int J Obes(Lond),2015,39(4):665-670.
[23] BECATTINI S,TAUR Y,PAMER E G.Antibiotic-induced changes in the intestinal microbiota and disease[J].Trends Mol Med,2016,22(6):458-478.
[24] ARON-WISNEWSKY J,CLÉMENT K,NIEUWDORP M.Fecal microbiota transplantation:a future therapeutic option for obesity/diabetes[J].Curr Diab Rep,2019,19(8):51.
[25] HU J,WANG X H,GAO S,et al.Research progress on role and mechanism of gut microbiota in cardiovascular diseases[J].Chin Pharmacol Bulletin,2019,35(11):1496-1500.
[26] ZHANG Z,MOCAN V,CAI C,et al.Impact of fecal microbiota transplantation on obesity and metabolic syndrome-a systematic review.[J].Nutrients,2019,11(10):468-473.
[27] GROOT P D,SCHEITHAUER T,BAKKER G J,et al.Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity,energy expenditure and intestinal transit time.[J].Gut,2020,69(3):502-512.
[28] TANG W H,KITAI T,HAZEN S L.Gut microbiota in cardiovascular health and disease[J].Circ Res,2017,120(7):1183-1196.
[29] DU Y,LI X X,SU C Y,et al.The human gut microbiome-a new and exciting avenue in cardiovascular drug discovery.[J].Expert Opin Drug Discov,2019,14(10):1037-1052.
[30] CHITTIM C L,MARTINEZ DEL CAMPO A,BALSKUS E P.Gut bacterial phospholipase ds support disease-associated metabolism by generating choline.[J].Nat Microbiol,2019,4(1):155-163.
[31] WANG G,HUANG W,XIA Y,et al.Cholesterol-lowering potentials of lactobacillus strain overexpression of bile salt hydrolase on high cholesterol diet-induced hypercholesterolemic mice.[J].Food Funct,2019,10(3):1684-1695.
[32] CHEN Y S,LIU H M,LI T Y.Ursodeoxycholic acid regulates hepatic energy homeostasis and white adipose tissue macrophages polarization in leptin-deficiency obese mice.[J].Cells,2019,8(3):1246-1258.
[33] KASAHARA K,KRAUTKRAMEA K A,ORG E,et al.Interactions between roseburia intestinalis and diet modulate atherogenesis in a murine model.[J].Nat Microbiol,2018,3(12):1461-1471. |
